While it might seem a little intimidating at first, the process is designed to be simple. However, it’s good to know what to do if an injection doesn’t go exactly as planned. This article will walk ...

Nucala (mepolizumab) and Dupixent (dupilumab) are prescription drugs used to treat chronic rhinosinusitis with nasal polyps, asthma, and COPD. Both drugs come as a liquid solution for injection under ...

Dupixent (dupilumab), a drug already used to treat atopic dermatitis and asthma, became the first biologic approved for chronic obstructive pulmonary disease (COPD) last fall. Most COPD treatments ...

Dupixent works by blocking two proteins in your body called IL-4 and IL-13 (interleukins). These are a specific type of protein that can trigger the immune system to respond as if there’s danger when ...

The FDA has approved Dupixent (dupilumab) for the treatment of children (aged 2 to 11 years) with chronic spontaneous urticaria (CSU).

Allergic fungal rhinosinusitis (AFRS) is a long-term inflammatory sinus condition. It happens when fungus, such as mold, grows in your nasal passages and your immune system has a strong allergic ...

TORONTO, Oct. 22, 2025 /CNW/ - Health Canada has approved Dupixent® (dupilumab injection) as an add-on maintenance treatment in adult patients with chronic obstructive pulmonary disease (COPD) ...